Delgocitinib cream is efficacious and well-tolerated for the treatment of adults with chronic hand eczema for up to 52 weeks.

Hand eczema may require diagnosis by a skin specialist called a dermatologist who can differentiate it from similar ...

In good news for patients living with chronic hand eczema (CHE), Leo Pharma – a company working to advance medical dermatology treatments – has unveiled positive topline results for its ...

Eczema, on the other hand, is a long-term, chronic condition that needs ongoing treatment and symptom management. Although the two conditions may have some similarities in their appearance ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Treatment with delgocitinib cream ... related quality of life in patients with moderate to severe chronic hand eczema (CHE), with those receiving delgocitinib cream 20 mg/g showed greater ...

Eczema outbreaks often ... drugs used for cancer treatment. It’s characterized by pain, swelling, and skin discoloration in the palms and soles of the hands and feet. It can also cause tingling ...

1 The findings from the post hoc analysis highlight that delgocitinib cream produced a strong treatment response across this subgroup of patients. A deep response, defined as a Hand Eczema Symptom ...

Infections Higher With JAK Inhibitors in Eczema Study A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to ...

Explore holistic approaches to treating the atopic triad in children—eczema, asthma, and allergies—with naturopathic ...